Atom Investors LP Ironwood Pharmaceuticals Inc Transaction History

Atom Investors LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $11.8 Million - $15.5 Million	-1,309,331 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $935,652 - $1.26 Million	103,387 Added 8.57%	1,309,331 $14.9 Million
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $1.35 Million - $1.61 Million	150,307 Added 14.24%	1,205,944 $10.8 Million
Q2 2020 Aug 14, 2020	SELL	$9.14 - $11.97 $380,178 - $497,892	-41,595 Reduced 3.79%	1,055,637 $10.9 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $6.38 Million - $10.4 Million	743,870 Added 210.51%	1,097,232 $11.1 Million
Q4 2019 Feb 13, 2020	SELL	$8.22 - $14.0 $2.74 Million - $4.67 Million	-333,592 Reduced 48.56%	353,362 $4.7 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $5.9 Million - $7.53 Million	686,954 New	686,954 $5.9 Million
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $1.25 Million - $1.64 Million	-127,364 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$8.27 - $12.73 $314,127 - $483,536	-37,984 Reduced 22.97%	127,364 $1.72 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $1.29 Million - $2.67 Million	165,348 New	165,348 $1.71 Million

245

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $224M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.